Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study
โ Scribed by Daniel O. Clegg; Domenic J. Reda; Edwin Mejias; Grant W. Cannon; Michael H. Weisman; Thomas Taylor; Elly Budiman-Mak; Warren D. Blackburn; Frank B. Vasey; Maren L. Mahowald; John J. Cush; H. Ralph Schumacher Jr.; Stuart L. Silverman; F. Paul Alepa; Michael E. Luggen; Miriam R. Cohen; Rama Makkena; Clair M. Haakenson; Richard H. Ward; B. J. Manaster; Robert J. Anderson; John R. Ward; William G. Henderson
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 689 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Objective. To determine if the peripheral articular manifestations of the seronegative spondylarthropathies (SNSA) respond differently than the axial manifestations to treatment with sulfasalazine (SSZ). Methods. This is a reanalysis of a previously reported series of randomized, double-blind, plac
Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula
In this study, Department of Veterans Affairs Fiscal Year 2006 national workload data are analyzed to determine use and intensity of outpatient individual and group psychotherapy and, using multivariate analysis, to identify sociodemographic and diagnostic correlates. Results show that among veteran